[go: up one dir, main page]

AU2001272719A1 - Macrolide antibiotics - Google Patents

Macrolide antibiotics

Info

Publication number
AU2001272719A1
AU2001272719A1 AU2001272719A AU7271901A AU2001272719A1 AU 2001272719 A1 AU2001272719 A1 AU 2001272719A1 AU 2001272719 A AU2001272719 A AU 2001272719A AU 7271901 A AU7271901 A AU 7271901A AU 2001272719 A1 AU2001272719 A1 AU 2001272719A1
Authority
AU
Australia
Prior art keywords
macrolide antibiotics
macrolide
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272719A
Other languages
English (en)
Inventor
Yan Chen
Wei-Guo Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of AU2001272719A1 publication Critical patent/AU2001272719A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2001272719A 2000-08-07 2001-08-06 Macrolide antibiotics Abandoned AU2001272719A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22359100P 2000-08-07 2000-08-07
US60223591 2000-08-07
PCT/IB2001/001403 WO2002012260A1 (fr) 2000-08-07 2001-08-06 Antibiotiques macrolides

Publications (1)

Publication Number Publication Date
AU2001272719A1 true AU2001272719A1 (en) 2002-02-18

Family

ID=22837162

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272719A Abandoned AU2001272719A1 (en) 2000-08-07 2001-08-06 Macrolide antibiotics

Country Status (17)

Country Link
US (2) US20020115621A1 (fr)
EP (1) EP1307468A1 (fr)
JP (1) JP2004505987A (fr)
AP (1) AP2001002236A0 (fr)
AR (1) AR034695A1 (fr)
AU (1) AU2001272719A1 (fr)
BR (1) BR0112863A (fr)
CA (1) CA2419044A1 (fr)
DO (1) DOP2001000228A (fr)
GT (1) GT200100159A (fr)
HN (1) HN2001000176A (fr)
MX (1) MXPA03001148A (fr)
PA (1) PA8524501A1 (fr)
PE (1) PE20020468A1 (fr)
TN (1) TNSN01121A1 (fr)
UY (1) UY26870A1 (fr)
WO (1) WO2002012260A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020016799A (ko) 1999-05-24 2002-03-06 데이비드 존 우드 13-메틸-에리트로마이신 유도체
AU6381201A (en) * 2000-03-28 2001-10-08 Biochemie Gmbh Granulated particles with masked taste
US6825172B2 (en) 2002-05-31 2004-11-30 Janssen Pharmaceutica, Nv 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
HRP20020885B1 (en) 2002-11-11 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
CA2529817C (fr) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Nouveaux agents antibacteriens
GB0310981D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
HRP20030381B1 (en) * 2003-05-14 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
WO2005030227A1 (fr) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. Derives 9a-azalide 11-3c-bicycliques
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2006080954A1 (fr) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Derives de cetolides agents antibacteriens
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
WO2006046112A2 (fr) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Derives de cetolides utiles comme agents antibacteriens
CA2591746A1 (fr) 2004-12-21 2006-06-29 Pfizer Products Inc. Macrolides
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
JP5036557B2 (ja) * 2005-01-13 2012-09-26 グラクソ グループ リミテッド 抗炎症活性デクラジノシル−マクロライド
US20090005325A1 (en) * 2005-11-23 2009-01-01 Biswajit Bas Ketolide Derivatives as Antibacterial Agents
US20090130225A1 (en) * 2005-11-23 2009-05-21 Anjan Chakrabarti Macrolides derivatives as antibacterial agents
AU2007256844A1 (en) * 2006-06-05 2007-12-13 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted erythromycin analogs
AU2008316830B2 (en) * 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2010048600A1 (fr) * 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Procédés de traitement de maladies résistantes en utilisant des macrolides contenant du triazole
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr) 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
EP2571506B1 (fr) 2010-05-20 2017-05-10 Cempra Pharmaceuticals, Inc. Procédés de préparation de macrolides et de kétolides et d'intermédiaires de ceux-ci
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (fr) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Formulations parentérales pour l'administration d'antibiotiques macrolides
EP2968801B1 (fr) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Procédés pour traiter des maladies respiratoires et formulations pour la mise en oeuvre de ceux-ci
MX356772B (es) 2013-03-15 2018-06-13 Cempra Pharmaceuticals Inc Procesos convergentes para la preparacion de agentes antibacterianos macrolidos.

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US40007A (en) 1863-09-22 Improvement in railroad-car brakes
US25937A (en) 1859-11-01 ballou
US61856A (en) 1867-02-05 Enos s
US61857A (en) 1867-02-05 Improvement in top-drivers or spinners
US100518A (en) 1870-03-08 Roland s
US156027A (en) 1874-10-20 Improvement in loom-shuttles
US3923784A (en) * 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
US5804565A (en) * 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
JP4077882B2 (ja) * 1996-11-27 2008-04-23 大正製薬株式会社 エリスロマイシンａ誘導体
AU6932098A (en) * 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
EP0895999A1 (fr) * 1997-08-06 1999-02-10 Pfizer Products Inc. Macrolides antibiotiques substitués C"-4
ZA987689B (en) * 1997-09-02 1999-02-24 Abbott Lab 3-descladinose 6-O substituted erythromycin derivatives
WO1999021870A1 (fr) 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Derives de l'erythromycine a 11,12-carbamate
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
JP2003527301A (ja) 1997-10-29 2003-09-16 大正製薬株式会社 エリスロマイシンａ誘導体
PA8461401A1 (es) * 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
CN1284961A (zh) * 1997-12-11 2001-02-21 北陆制药株式会社 红霉素衍生物
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
US6248719B1 (en) * 1998-06-03 2001-06-19 Pfizer Inc Tricyclic 3-keto derivatives of 6-O-methylerthromycin
OA11753A (en) 1999-01-27 2005-07-19 Pfizer Prod Inc Ketolide antibiotics.
AU6183800A (en) 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO2001010878A1 (fr) 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
US6498146B1 (en) * 1999-10-28 2002-12-24 Pfizer Inc Erythromycin derivatives
EP1101769A3 (fr) * 1999-11-18 2001-10-24 Pfizer Products Inc. Dérivés de l'érythromycine contenant de l'azote

Also Published As

Publication number Publication date
CA2419044A1 (fr) 2002-02-14
US20040009930A1 (en) 2004-01-15
PE20020468A1 (es) 2002-06-14
GT200100159A (es) 2002-03-22
PA8524501A1 (es) 2002-08-29
AP2001002236A0 (en) 2001-09-30
US20020115621A1 (en) 2002-08-22
AR034695A1 (es) 2004-03-17
WO2002012260A1 (fr) 2002-02-14
US6849608B2 (en) 2005-02-01
EP1307468A1 (fr) 2003-05-07
MXPA03001148A (es) 2003-06-09
UY26870A1 (es) 2002-03-22
HN2001000176A (es) 2001-10-08
TNSN01121A1 (fr) 2005-11-10
JP2004505987A (ja) 2004-02-26
DOP2001000228A (es) 2002-09-30
BR0112863A (pt) 2003-07-01

Similar Documents

Publication Publication Date Title
EP1363925B8 (fr) Antibiotiques a base de macrolides
AU2002217277A1 (en) Macrolide antibiotics
AU2001272719A1 (en) Macrolide antibiotics
AU2001284934A1 (en) Steroid derived antibiotics
IL144178A0 (en) Ketolide antibiotics
AU2001228708A1 (en) Coin-validation arrangement
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
PL348114A1 (en) Novel macrolide antibiotics
AU2001258349A1 (en) Bisacylguanidine
AU4657001A (en) Displacing arrangement
AU2001278694A1 (en) Avermectin derivatives
AU2002221895A1 (en) Macrolide solvates
AU2001257490A1 (en) Improved beta-lactam antibiotics
AU2001253911A1 (en) Bifunctional antibiotics
AU2001258924A1 (en) Microsatellite-aflp
AU2002230386A1 (en) Sixteen-membered macrolide compounds
AU2002359761A1 (en) Antibiotic compounds
AU2001246864A1 (en) Hypotensors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001238020A1 (en) Glycopeptide derivatives having antibiotic activity
EP1201403A3 (fr) Eléments électrosoudables
AU2002246567A1 (en) Aminoglycosides as antibiotics